Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Targeted Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global HER2 Targeted Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Head and Neck Cancer
1.3.5 Lung Cancer
1.3.6 Ovarian Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Targeted Therapy Market Perspective (2018-2033)
2.2 HER2 Targeted Therapy Growth Trends by Region
2.2.1 Global HER2 Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 HER2 Targeted Therapy Historic Market Size by Region (2018-2023)
2.2.3 HER2 Targeted Therapy Forecasted Market Size by Region (2024-2033)
2.3 HER2 Targeted Therapy Market Dynamics
2.3.1 HER2 Targeted Therapy Industry Trends
2.3.2 HER2 Targeted Therapy Market Drivers
2.3.3 HER2 Targeted Therapy Market Challenges
2.3.4 HER2 Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Targeted Therapy Players by Revenue
3.1.1 Global Top HER2 Targeted Therapy Players by Revenue (2018-2023)
3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global HER2 Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HER2 Targeted Therapy Revenue
3.4 Global HER2 Targeted Therapy Market Concentration Ratio
3.4.1 Global HER2 Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Targeted Therapy Revenue in 2022
3.5 HER2 Targeted Therapy Key Players Head office and Area Served
3.6 Key Players HER2 Targeted Therapy Product Solution and Service
3.7 Date of Enter into HER2 Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Targeted Therapy Breakdown Data by Type
4.1 Global HER2 Targeted Therapy Historic Market Size by Type (2018-2023)
4.2 Global HER2 Targeted Therapy Forecasted Market Size by Type (2024-2033)
5 HER2 Targeted Therapy Breakdown Data by Application
5.1 Global HER2 Targeted Therapy Historic Market Size by Application (2018-2023)
5.2 Global HER2 Targeted Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America HER2 Targeted Therapy Market Size (2018-2033)
6.2 North America HER2 Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America HER2 Targeted Therapy Market Size by Country (2018-2023)
6.4 North America HER2 Targeted Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 Targeted Therapy Market Size (2018-2033)
7.2 Europe HER2 Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe HER2 Targeted Therapy Market Size by Country (2018-2023)
7.4 Europe HER2 Targeted Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 Targeted Therapy Market Size (2018-2033)
8.2 Asia-Pacific HER2 Targeted Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific HER2 Targeted Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific HER2 Targeted Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 Targeted Therapy Market Size (2018-2033)
9.2 Latin America HER2 Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America HER2 Targeted Therapy Market Size by Country (2018-2023)
9.4 Latin America HER2 Targeted Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Targeted Therapy Market Size (2018-2033)
10.2 Middle East & Africa HER2 Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa HER2 Targeted Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa HER2 Targeted Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline HER2 Targeted Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in HER2 Targeted Therapy Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer HER2 Targeted Therapy Introduction
11.2.4 Bayer Revenue in HER2 Targeted Therapy Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott HER2 Targeted Therapy Introduction
11.3.4 Abbott Revenue in HER2 Targeted Therapy Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie HER2 Targeted Therapy Introduction
11.4.4 AbbVie Revenue in HER2 Targeted Therapy Business (2018-2023)
11.4.5 AbbVie Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer HER2 Targeted Therapy Introduction
11.5.4 Pfizer Revenue in HER2 Targeted Therapy Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi HER2 Targeted Therapy Introduction
11.6.4 Sanofi Revenue in HER2 Targeted Therapy Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent HER2 Targeted Therapy Introduction
11.7.4 Agilent Revenue in HER2 Targeted Therapy Business (2018-2023)
11.7.5 Agilent Recent Development
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Company Detail
11.8.2 Glenmark Pharmaceuticals Business Overview
11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Introduction
11.8.4 Glenmark Pharmaceuticals Revenue in HER2 Targeted Therapy Business (2018-2023)
11.8.5 Glenmark Pharmaceuticals Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck HER2 Targeted Therapy Introduction
11.9.4 Merck Revenue in HER2 Targeted Therapy Business (2018-2023)
11.9.5 Merck Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche HER2 Targeted Therapy Introduction
11.10.4 Roche Revenue in HER2 Targeted Therapy Business (2018-2023)
11.10.5 Roche Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis HER2 Targeted Therapy Introduction
11.11.4 Novartis Revenue in HER2 Targeted Therapy Business (2018-2023)
11.11.5 Novartis Recent Development
11.12 Astra Zeneca
11.12.1 Astra Zeneca Company Detail
11.12.2 Astra Zeneca Business Overview
11.12.3 Astra Zeneca HER2 Targeted Therapy Introduction
11.12.4 Astra Zeneca Revenue in HER2 Targeted Therapy Business (2018-2023)
11.12.5 Astra Zeneca Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Detail
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo HER2 Targeted Therapy Introduction
11.13.4 Daiichi Sankyo Revenue in HER2 Targeted Therapy Business (2018-2023)
11.13.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HER2 Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Key Players of Others
Table 5. Global HER2 Targeted Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global HER2 Targeted Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global HER2 Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global HER2 Targeted Therapy Market Share by Region (2018-2023)
Table 9. Global HER2 Targeted Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global HER2 Targeted Therapy Market Share by Region (2024-2033)
Table 11. HER2 Targeted Therapy Market Trends
Table 12. HER2 Targeted Therapy Market Drivers
Table 13. HER2 Targeted Therapy Market Challenges
Table 14. HER2 Targeted Therapy Market Restraints
Table 15. Global HER2 Targeted Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global HER2 Targeted Therapy Market Share by Players (2018-2023)
Table 17. Global Top HER2 Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Targeted Therapy as of 2022)
Table 18. Ranking of Global Top HER2 Targeted Therapy Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by HER2 Targeted Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players HER2 Targeted Therapy Product Solution and Service
Table 22. Date of Enter into HER2 Targeted Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HER2 Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global HER2 Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global HER2 Targeted Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global HER2 Targeted Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global HER2 Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global HER2 Targeted Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global HER2 Targeted Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global HER2 Targeted Therapy Revenue Market Share by Application (2024-2033)
Table 32. North America HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific HER2 Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific HER2 Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific HER2 Targeted Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa HER2 Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa HER2 Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa HER2 Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline HER2 Targeted Therapy Product
Table 50. GlaxoSmithKline Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Bayer Company Detail
Table 53. Bayer Business Overview
Table 54. Bayer HER2 Targeted Therapy Product
Table 55. Bayer Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. Abbott Company Detail
Table 58. Abbott Business Overview
Table 59. Abbott HER2 Targeted Therapy Product
Table 60. Abbott Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. AbbVie Company Detail
Table 63. AbbVie Business Overview
Table 64. AbbVie HER2 Targeted Therapy Product
Table 65. AbbVie Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer HER2 Targeted Therapy Product
Table 70. Pfizer Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi HER2 Targeted Therapy Product
Table 75. Sanofi Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Agilent Company Detail
Table 78. Agilent Business Overview
Table 79. Agilent HER2 Targeted Therapy Product
Table 80. Agilent Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. Glenmark Pharmaceuticals Company Detail
Table 83. Glenmark Pharmaceuticals Business Overview
Table 84. Glenmark Pharmaceuticals HER2 Targeted Therapy Product
Table 85. Glenmark Pharmaceuticals Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 86. Glenmark Pharmaceuticals Recent Development
Table 87. Merck Company Detail
Table 88. Merck Business Overview
Table 89. Merck HER2 Targeted Therapy Product
Table 90. Merck Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Roche Company Detail
Table 93. Roche Business Overview
Table 94. Roche HER2 Targeted Therapy Product
Table 95. Roche Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 96. Roche Recent Development
Table 97. Novartis Company Detail
Table 98. Novartis Business Overview
Table 99. Novartis HER2 Targeted Therapy Product
Table 100. Novartis Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Astra Zeneca Company Detail
Table 103. Astra Zeneca Business Overview
Table 104. Astra Zeneca HER2 Targeted Therapy Product
Table 105. Astra Zeneca Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 106. Astra Zeneca Recent Development
Table 107. Daiichi Sankyo Company Detail
Table 108. Daiichi Sankyo Business Overview
Table 109. Daiichi Sankyo HER2 Targeted Therapy Product
Table 110. Daiichi Sankyo Revenue in HER2 Targeted Therapy Business (2018-2023) & (US$ Million)
Table 111. Daiichi Sankyo Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Targeted Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global HER2 Targeted Therapy Market Share by Type: 2022 VS 2033
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Others Features
Figure 6. Global HER2 Targeted Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global HER2 Targeted Therapy Market Share by Application: 2022 VS 2033
Figure 8. Breast Cancer Case Studies
Figure 9. Stomach Cancer Case Studies
Figure 10. Head and Neck Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Ovarian Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. HER2 Targeted Therapy Report Years Considered
Figure 15. Global HER2 Targeted Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global HER2 Targeted Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global HER2 Targeted Therapy Market Share by Region: 2022 VS 2033
Figure 18. Global HER2 Targeted Therapy Market Share by Players in 2022
Figure 19. Global Top HER2 Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Targeted Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by HER2 Targeted Therapy Revenue in 2022
Figure 21. North America HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 23. United States HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 27. Germany HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific HER2 Targeted Therapy Market Share by Region (2018-2033)
Figure 35. China HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 43. Mexico HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa HER2 Targeted Therapy Market Share by Country (2018-2033)
Figure 47. Turkey HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia HER2 Targeted Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. GlaxoSmithKline Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 50. Bayer Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 51. Abbott Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 52. AbbVie Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 55. Agilent Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 56. Glenmark Pharmaceuticals Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 58. Roche Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 60. Astra Zeneca Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 61. Daiichi Sankyo Revenue Growth Rate in HER2 Targeted Therapy Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed